Centered in Neurology, the multidisciplinary Michigan Alzheimer’s Disease Center (MADC) is the hub of an aggressive campus-wide effort working toward a better understanding of, and eventually a cure for, Alzheimer's and related dementias. Tapping the power of the University’s top-ranked programs and world-class researchers, we attack these diseases with a range of promising approaches:
Defining disease mechanisms: We investigate how the brain handles toxic proteins in various dementias in the hope that we can clear these bad actors from the brain.
Discovering biomarkers: We explore novel disease biomarkers that will improve diagnosis and may lead us to targeted clinical treatments.
Pioneering brain imaging: We apply advanced imaging techniques to achieve earlier and more accurate diagnosis and to make discoveries about disease pathways.
Seeking therapies: We participate in a growing number of clinical trials that test potential disease-slowing therapy for Alzheimer's.
Improving brain health: We sponsor innovative wellness programs for patients,families and caregivers that focus on improving the lives of those living with or affected by the disease.